| Substrate-targeting gamma-secretase modulators TL Kukar, TB Ladd, MA Bann, PC Fraering, R Narlawar, GM Maharvi, ... Nature 453 (7197), 925-929, 2008 | 377 | 2008 |
| Curcumin‐derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease? R Narlawar, M Pickhardt, S Leuchtenberger, K Baumann, S Krause, ... ChemMedChem: Chemistry Enabling Drug Discovery 3 (1), 165-172, 2008 | 205 | 2008 |
| Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3, 4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor L Ramos, C Hicks, R Kevin, A Caminer, R Narlawar, M Kassiou, ... Neuropsychopharmacology 38 (11), 2249-2259, 2013 | 138 | 2013 |
| Hybrid Ortho/Allosteric Ligands for the Adenosine A1 Receptor R Narlawar, JR Lane, M Doddareddy, J Lin, J Brussee, AP IJzerman Journal of medicinal chemistry 53 (8), 3028-3037, 2010 | 109 | 2010 |
| Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition RA Habets, CE de Bock, L Serneels, I Lodewijckx, D Verbeke, D Nittner, ... Science Translational Medicine 11 (494), eaau6246, 2019 | 94 | 2019 |
| Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non‐peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study … C Hicks, L Ramos, T Reekie, GH Misagh, R Narlawar, M Kassiou, ... British journal of pharmacology 171 (11), 2868-2887, 2014 | 86 | 2014 |
| Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor LH Heitman, R Narlawar, H de Vries, MN Willemsen, D Wolfram, ... Journal of medicinal chemistry 52 (7), 2036-2042, 2009 | 59 | 2009 |
| Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor LH Heitman, R Narlawar, H de Vries, MN Willemsen, D Wolfram, ... Journal of medicinal chemistry 52 (7), 2036-2042, 2009 | 59 | 2009 |
| Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer γ-secretase modulators R Narlawar, BI Pérez Revuelta, C Haass, H Steiner, B Schmidt, ... Journal of medicinal chemistry 49 (26), 7588-7591, 2006 | 53 | 2006 |
| Drug development and PET-diagnostics for Alzheimer's disease B Schmidt, HA Braun, R Narlawar Current medicinal chemistry 12 (14), 1677-1695, 2005 | 53 | 2005 |
| Curcumin derivatives inhibit or modulate beta-amyloid precursor protein metabolism R Narlawar, K Baumann, R Schubenel, B Schmidt Neurodegenerative diseases 4 (2-3), 88-93, 2007 | 45 | 2007 |
| N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated γ-secretase R Narlawar, BI Pérez Revuelta, K Baumann, R Schubenel, C Haass, ... Bioorganic & Medicinal Chemistry Letters 17 (1), 176-182, 2007 | 42 | 2007 |
| Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms K Bernard, W Wang, R Narlawar, B Schmidt, KL Kirk Journal of biological chemistry 284 (45), 30754-30765, 2009 | 41 | 2009 |
| Correction to Synthesis of Usnic Acid Derivatives and Evaluation of Their Antiproliferative Activity against Cancer Cells MK Agnieszka Pyrczak-Felczykowska, Rajeshwar Narlawar, Anna Pawlik, Beata ... Journal of Natural Products 83 (2), 563-564, 2020 | 33* | 2020 |
| Synthesis of Usnic Acid Derivatives and Evaluation of Their Antiproliferative Activity against Cancer Cells A Pyrczak-Felczykowska, R Narlawar, A Pawlik, B Guzow-Krzemińska, ... Journal of Natural Products 82 (7), 1768-1778, 2019 | 33 | 2019 |
| A carbocyclic curcumin inhibits proliferation of Gram positive bacteria by targeting FtsZ PW Groundwater, R Narlawar, VWY Liao, A Bhattacharya, S Srivastava, ... Biochemistry 56 (3), 514−524, 2017 | 32 | 2017 |
| WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action C Hicks, L Ramos, TA Reekie, R Narlawar, M Kassiou, IS McGregor Psychopharmacology 232, 2659-2667, 2015 | 24 | 2015 |
| MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors L Ramos, C Hicks, A Caminer, K Couto, R Narlawar, M Kassiou, ... Pharmacology Biochemistry and Behavior 150, 115-123, 2016 | 23 | 2016 |
| Conversion of the LXR-agonist TO-901317—From inverse to normal modulation of γ-secretase by addition of a carboxylic acid and a lipophilic anchor R Narlawar, K Baumann, C Czech, B Schmidt Bioorganic & medicinal chemistry letters 17 (19), 5428-5431, 2007 | 23 | 2007 |
| Modulators and Inhibitors of γ-and β-Secretases B Schmidt, S Baumann, R Narlawar, HA Braun, G Larbig Neurodegenerative Diseases 3 (4-5), 290-297, 2006 | 20 | 2006 |
Michael KassiouProfessor of Medicinal Chemistry, The University of SydneyVerified email at sydney.edu.au
